NCT04950907

Uniportal Tubeless VATS for the Evaluation of Biopsy for Second-generation Sequencing in Patients With Advanced NSCLC

A Randomized Controlled Study of Single Port Tubeless VATS for the Evaluation of Qualified Rate of Biopsy for Second-generation Tibial Specimens in Patients With Advanced NSCLC

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 94 (estimated)
• Sponsor: Jianxing He · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The study is a single-center, prospective, open-label randomized controlled study. This study evaluates the eligibility rate of different biopsy methods (tubeless tubeless VATS vs. CT guided fine needle aspiration) for the detection of molecular genetic characteristics of peripheral NSCLC next-generation sequencing, and its main purpose is to evaluate the use of tumor gene profiling (NGS) The best biopsy technique, the First Affiliated Hospital of Guangzhou Medical University is the research center. It is expected to be completed between 2021-3-1 and 2023-3-1.

Conditions

• NSCLC
• Biopsy Technique
• VATS
• CT Guided Puncture Biopsy
• NGS

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	vats	Use uniportal tubeless VATS to obtain the biopsy
DIAGNOSTIC_TEST	CT-guided fine needle biopsy	Use CT-guided fine needle to obtain the biopsy

Timeline

• Start date: 2021-07-15
• Primary completion: 2023-06-26
• Completion: 2024-06-26
• First posted: 2021-07-06
• Last updated: 2021-07-13